We have shown that PAR1 as a direct transcriptional target of Twist, can promote EMT, migration, invasion, tumorigenicity, and lung metastasis of breast cancer cells through suppressing the Hippo pathway, providing a potential therapeutic target for the treatment of invasive breast cancer. Here, F2R is linked to invasive breast carcinoma.